10. Oppfølging og etterkontroll etter avsluttet kurativ behandling

Balch, C. M., Houghton, A. N., Milton, G. W. (1992). Cutaneous Melanoma. Lippincott.

Bello, D. M., Chou, J. F., Panageas, K. S., Brady, M. S., Coit, D. G., Carvajal, R. D., & Ariyan, C. E. (2013). Prognosis of acral melanoma: a series of 281 patients. Annals of surgical oncology, 20(11), 3618-25.

Bradford, P. T., Goldstein, A. M., McMaster, M. L., & Tucker, M. A. (2009). Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Archives of dermatology, 145(4), 427-34.

Cancer Council Australia, Australian Cancer Network, Ministry of Health (2008). Cancer Practice Guidelines for the Management of Melanoma in Australia and New Zealand: Evidence-based Best Practice Guidelines Wellington: Cancer Council Australia, Australian Cancer Network and Ministry of Health, New Zealand.

Chopra, A., Sharma, R., & Rao, U. N. M. (2020). Pathology of Melanoma. The Surgical clinics of North America, 100(1), 43-59.

Dansk Melanom Gruppe (2013). DMG Guidelines 2013 Herlev: Dansk Melanom Gruppe. Hentet fra http://www.melanoma.dk/

Dessinioti, C., Dimou, N., Geller, A. C., Stergiopoulou, A., Lo, S., Keim, U., Gershenwald, J. E., Haydu, L. E., ... Stratigos, A. J. (2019). Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers. Journal of the National Cancer Institute, 111(12), 1314-1322.

Dummer, R., Guggenheim, M., Arnold, A. W., Braun, R., & von Moos, R. (2011). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss medical weekly, 141, w13320.

Garbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Reinhold, U., Kortmann, R. D., Kettelhack, C., ... Kaufmann, R. (2007). Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma research, 17(6), 393-9.

Helsedirektoratet (2017). Seneffekter etter kreftbehandling: faglige råd (IS-2551). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/publikasjoner/seneffekter-etter-kreft

Larsen, I. K. (2021). Cancer in Norway 2020: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Lattanzi, M., Lee, Y., Simpson, D., Moran, U., Darvishian, F., Kim, R. H., Hernando, E., Polsky, D., ... Osman, I. (2019). Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy. Journal of the National Cancer Institute, 111(2), 180-188.

Livingstone, E., Krajewski, C., Eigentler, T. K., Windemuth-Kieselbach, C., Benson, S., Elsenbruch, S., Hauschild, A., Rompel, R., ... Schadendorf, D. (2015). Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study. European journal of cancer, 51(5), 653-67.

NCCN (2013). NCCN Clinical Practice Guidelines in Oncology: Melanoma Fort Washington, PA: National Comprehensive Cancer Network.

NICE (2015). Melanoma: assessment and management (NICE guideline NG14). Cardiff: National Collaborating Centre for Cancer. Hentet fra http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0079031/pdf/PubMedHealth_PMH0079031.pdf

Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010). Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. Journal of clinical oncology, 28(18), 3042-7.

Rueth, N. M., Cromwell, K. D., & Cormier, J. N. (2015). Long-term follow-up for melanoma patients: is there any evidence of a benefit?. Surgical oncology clinics of North America, 24(2), 359-77.

Rueth, N. M., Xing, Y., Chiang, Y. J., Cromwell, K. D., Ross, M. I., Lee, J. E., Gershenwald, J. E., Royal, R. E., & Cormier, J. N. (2014). Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Annals of surgery, 259(6), 1215-22.

Rutkowski, P., & Lugowska, I. (2014). Follow-up in melanoma patients. Memo, 7(2), 83-86.

Svedman, F. C., Pillas, D., Taylor, A., Kaur, M., Linder, R., & Hansson, J. (2016). Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clinical Epidemiology, 8, 109-22.

Trotter, S. C., Sroa, N., Winkelmann, R. R., Olencki, T., & Bechtel, M. (2013). A Global Review of Melanoma Follow-up Guidelines. The Journal of clinical and aesthetic dermatology, 6(9), 18-26.

Voit, C., Van Akkooi, A. C., Schafer-Hesterberg, G., Schoengen, A., Kowalczyk, K., Roewert, J. C., Sterry, W., & Eggermont, A. M. (2010). Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. Journal of clinical oncology, 28(5), 847-52.

Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., Royal, R., & Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. Journal of the National Cancer Institute, 103(2), 129-42.